[Abstract Only] Randomized Trial: Dual Antiplatelet Therapy vs. Monotherapy with a P2Y12 Inhibitor in High-Risk Patients after PCI
27 Sep, 2019 | 08:25h | UTCTicagrelor with or without Aspirin in High-Risk Patients after PCI – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention – TWILIGHT – American College of Cardiology (free) AND TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events – TCTMD (free)